gip-1 vs glp-1 The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology Beyond the pancreas: contrasting cardiometabolic

BPC-157 10mg BPC-157 Overview BPC-157 (Body Protection Compound-157) is a synthetic peptide consisting of 15 amino acids derived from a protective protein sequence found within human gastric juice

Most people experience rebound weight gain when they stop taking the drugs, and repeated yo yo effect can leave people feeling depressed

HistoIndexs AI-based fibrosis assessment uses advanced digital pathology techniques to provide detailed and precise analysis of liver tissue, helping to better understand fibrosis dynamics and treatment responses

However, given the positive CV outcomes, a slight increased heart rate doesnt seem to translate into adverse outcomes